Members of the basic helix-loop-helix family of DNA binding proteins have important roles in the development of subpopulations of neural crest-derived neurons. We have cloned the chicken homologues of dHAND (HAND2) and eHAND (HAND1), basic helix-loop-helix DNA binding proteins whose neuronal expression is restricted to sympathetic and enteric neural crest-derived ganglia. Transcripts encoding dHAND and eHAND are expressed in sympathetic ganglia beginning at Hamburger and Hamilton stage 17-18. Antisense blockade of transcripts encoding HAND genes in neural crest-derived cells in vitro results in a significant reduction in neurogenesis. Differentiation of catecholaminergic neurons is also reduced by 52% if the expression of transcripts encoding dHAND and eHAND is reduced using antisense oligonucleotide blockade. The effect on neurogenesis and phenotypic expression of neural crest-derived neurons is specific; blockade of HAND gene expression has no apparent influence on the differentiation in vitro of neural tube-derived neurons. Use of a replicationcompetent avian retrovirus to constitutively express HAND genes in neural crest-derived cells in vitro, under nonpermissive growth conditions in medium supplemented with 2% chick embryo extract (CEE), induced precocious catecholaminergic differentiation. Constitutive expression of HAND gene products resulted in a significant increase in catecholaminergic differentiation of cells grown in medium supplemented with 10% CEE, a permissive growth condition for catecholaminergic development. These results suggest that the expression by neural crest cells of dHAND and eHAND may be both sufficient and necessary for catecholaminergic phenotypic expression.
INTRODUCTION
The neural crest of vertebrate embryos is composed of a population of progenitor cells that are highly migratory and multipotent. Neural crest-derived cells give rise to a large array of differentiated cell types, including neurons and support cells of the peripheral nervous system, bones and muscles of the face, endocrine cells, and melanocytes. Phenotypic choice and expression are established predominantly through environmental cues encountered during their migration or at their final sites of localization (for review see Stemple and Anderson, 1993; Le Douarin and Dupin, 1993; Dupin et al., 1993; Anderson, 1993; Groves and Anderson, 1996) . Among the environmental signals that have been demonstrated to affect neural crest development are growth factors and extracellular matrix molecules. Although many interactions have been documented little is understood about the mechanisms of action of these signaling molecules. Ultimately, the result of signaling imparted by growth factors and extracellular matrix molecules is changes in gene expression.
During nervous system development, neurogenesis is controlled by transcription factors acting in a stage-specific and site-specific manner. Members of the basic helix-loophelix (bHLH) family of transcription factors have been shown to play key roles in cell-type determination and differentiation during neurogenesis, myogenesis, and hema-topoesis (Ghysen and Dambly-Chaudiere, 1989; Baer, 1993; Jan, 1993, 1994; Venuti and Cserjesi, 1996; Anderson, 1997) . They function mainly as heterodimers or homodimers to influence transcription of E-box-containing genes. Many bHLH genes are neurogenic and related to the proneural and neurogenic genes of Drosophila (reviewed in Campos-Ortega, 1995) . Of particular interest are the acheate-scute proneural genes and atonal. The expression of these genes influences the potential for development of specific subclasses of neurons (Campuzano and Modollel, 1992) . The vertebrate homologues of many of the Drosophila proneural and neurogenic genes have been cloned. The best characterized is MASH1 (Guillemot et al., 1993; Anderson, 1993) . MASH1 is the vertebrate homologue of the Drosophila proneural gene complex achaete-scute (Johnson et al., 1990) and is essential for development of subsets of neural crest-derived peripheral neurons as well as neural tube-derived central nervous system neurons (Guillemot et al., 1993; Lo et al., 1994; Sommer et al., 1995; Anderson, 1997) . Transcripts encoding MASH1 have been localized in neural crest-derived sympathetic, parasympathetic, and enteric neurons. MASH1 expression is first observed after neural crest-derived cells have migrated and localized in sites where they will differentiate. In rodents, MASH1 regulates the downstream expression of transcriptional activators required for aspects of catecholaminergic neuron expression (Hirsch et al., 1998) . Expression of the paired homeodomain transcription factor, Phox2a, which is a positive regulator of the dopamine-␤-hydroxylase gene, can be regulated by MASH1 (Lo et al., 1999) . Interference of MASH1 expression by targeted gene disruption results in a loss of sympathetic, olfactory, and a subset of enteric neurons (Guillemot and Joyner, 1993; Guillemot et al., 1993; Blaugrund et al., 1996) , demonstrating that the development of some neural crest-derived neuronal lineages is MASH1 dependent (Gershon, 1997) . Although the expression of MASH1 is required for differentiation of sympathetic neurons it is not sufficient Sommer et al., 1995) , suggesting the requirement for additional transcriptional regulators acting either in series or in parallel with MASH1.
Several other neurogenic bHLH factors that have a more restricted pattern of expression than does MASH1 have been identified. One such factor is NeuroD, which, in addition to being expressed in the central nervous system, is expressed in neural crest-derived sensory neurons exclusively (Lee et al., 1995) . NeuroD is expressed in postmitotic neural precursors (Lee et al., 1995) . Ectopic expression of NeuroD results in the premature differentiation of neuronal precursors as well as the expression of neuronal characteristics in cells that would not normally differentiate as neurons, suggesting that NeuroD functions as a differentiation regulator during neurogenesis (Lee et al., 1995) . The HAND genes, novel members of the bHLH group, show an even more restricted pattern of expression than MASH1 or NeuroD, being exclusively expressed in sympathetic and enteric neural crest-derived neurons .
The expression of transcripts encoding dHAND (HAND2) and eHAND (HAND1) has been previously described in avians (Srivastava et al., 1996) and rodents Hollenberg et al., 1995) . In avians, reducing expression of transcripts encoding dHAND and eHAND in situ using antisense oligonucleotides results in arrest of cardiac development at the looping heart stage (Srivastava et al., 1996) . Targeted mutation of dHAND and eHAND results in death secondary to failure of normal cardiogenesis (Riley et al., 1998) and abnormal trophoblast development (Firulli et al., 1998) , respectively. The early time of appearance of transcripts encoding dHAND and eHAND, well-defined sites of localization, and the overlapping patterns of transcript localization with MASH1 (Anderson, 1993; Blaugrund et al., 1996) suggest that the HAND genes also have a significant role in sympathetic neuronal development.
Transcriptional activators/repressors function in a hierarchical manner often acting in groups with parallel or series patterns of activation. While the interactions of transcriptional regulators required for differentiation of sympathetic neural crest-derived neurons are poorly understood, MASH1 is required for both the expression of panneuronal characteristics and cell-type-specific aspects of catecholaminergic neural crest-derived differentiation Hirsch et al., 1998) . In the current study we provide evidence that two additional bHLH transcription factors, dHAND and eHAND, are required for differentiation of catecholaminergic neurons and suggest that they function in conjunction with MASH1 in the determination of aspects of cell-type-specific expression of catecholaminergic neurons.
MATERIALS AND METHODS

Cloning
dHAND and eHAND were cloned from a chicken embryo library prepared from stage 14 -17 embryos in Lambda ZAP II and titered at 5 ϫ 10 6 PFU/ml. The library was screened using conventional methods (Sambrook et al., 1989) . Bacteriophage were transferred in duplicate to Hybond-N nylon membranes (Amersham, Arlington Heights, IL). Filters were incubated at 37°C in prehybridization solution containing 6ϫ SSC, 5ϫ Denhardt's reagent, 50 g/ml denatured salmon sperm DNA, 35% formamide, 0.5% SDS for 4 -5 h. The filters were hybridized overnight in the same solution containing heat-denatured random primed 32 P-labeled PCRgenerated DNA corresponding to bases 244 -493 of mouse dHAND and 534 -928 of mouse eHAND (Srivastava et al., 1995; . Radioactivity nonspecifically bound was removed by washing at room temperature in 2ϫ SSC, 0.1% SDS for 15 min twice, followed by two 15-min washes in 2ϫ SSC and 0.1% SDS at 45°C. The filters were exposed to Kodak XAR-5 film for 1 day at Ϫ80°C with an intensifying screen. Eighteen positive plaques were isolated from three primary plates containing 5 ϫ 10 5 recombinants per plate. Plaques were purified by rescreening two times and phage DNA stocks prepared from each of nine clones. cDNA inserts were subcloned into the phagemid pBluescript II KS(ϩ) (Stratagene, La Jolla, CA) and used to transform HB101 bacteria for subsequent sequencing and probe synthesis.
Tissue Culture
Neural crest cells were obtained from stage 13 (Zacchei, 1961) Japanese quail embryos (Coturnix coturnix japonica) for all experiments. Fertilized virus-free quail eggs (Karasoulas Farms, Lake Elsinore, CA) were incubated at 38°C for 46 -47 h. The neural tube and associated somites were surgically removed from embryos using electrolytically sharpened tungsten needles. The neural tube fragments were incubated in 0.5% collagenase A (Boehringer Mannheim, Indianapolis, IN) for 12 min at room temperature. The neural tubes were released using gentle trituration with firepolished Pasteur pipettes. The neural tubes were collected in fresh growth medium and washed in one additional change of fresh growth medium and plated on 35-mm tissue culture plates coated with 24 g/ml fibronectin (Gibco BRL, Grand Island, NY). The neural tube explants were removed from the dish using tungsten needles after 14 -16 h, leaving behind the neural crest cells that had migrated out onto the dish, unless otherwise indicated. In studies in which the neural tubes were removed, culture plates were carefully screened on day 2 for the presence of motoneurons indicating that neural tube cells had been left on the dish. For these studies, no dishes containing motoneurons were used in the analysis. At the time the explants were removed or after 48 h in cultures in which the neural tube was not removed, growth medium was changed and every other day thereafter, for the 7-day culture period.
Growth Media
Neural crest cell cultures were fed with medium containing Eagle's minimal essential medium (Gibco BRL) supplemented with 15% horse serum and 2 or 10% 11-day chick embryo extract (CEE) prepared as previously described (Howard and Bronner-Fraser, 1985) . DF-1 cells (see below) were maintained in Dulbecco's modified Eagle's medium plus 10% fetal calf serum.
Whole-Mount in Situ Hybridization
Embryos were removed from eggs and fixed in 4% paraformaldehyde in calcium-magnesium-free phosphate-buffered saline for 24 h at room temperature. The fixed embryos were rinsed in 70% ethanol and stored at Ϫ20°C in 70% ethanol until use. Wholemount in situ hybridization using digoxigenin-labeled cRNA probes was done according to Barth and Ivarie (1994) . cRNA probes corresponded to the full-length chicken cDNAs encoding dHAND or eHAND. Embryos were digested with proteinase K (30 g/ml) for 7 min and incubated at 60°C for 2 h in a prehybridization solution containing NaCl (600 mM), Tris, pH 7.5 (10 mM), Denhardt's reagent (1ϫ), EDTA (0.5 mM), sheared DNA (0.01%), yeast total RNA (0.05%), yeast tRNA (0.005%), and formamide (50%). The embryos were hybridized at 60°C in fresh prehybridization buffer to which dextran sulfate (10%) and 250 ng/ml digoxigenin-labeled riboprobe was added. Embryos were washed over a period of 30 h in prehybridization solution at 60°C and then rinsed 2ϫ 30 min in phosphate-buffered saline containing 0.3% Triton X-100 at room temperature. Hybrids were detected following incubation in antidigoxigenin FAB fragment conjugated to alkaline phosphate (1: 2000) in phosphate-buffered saline containing 0.3% Triton X-100 overnight at 4°C. Embryos were incubated in color-detection reagent (NBT and BCIP) according to the manufacturer's instructions (Boehringer Mannheim) following washing in 100 mM Tris, pH 9.5, 150 mM NaCl, 25 mM MgCl 2 . The color reaction was stopped by the addition of TE, pH 8.0.
Immunocytochemistry
Immunocytochemistry was performed as previously described (Howard and Gershon, 1993) . Briefly, cells were washed three times 5 min in phosphate buffered saline (PBS) and fixed in 4% formaldehyde, prepared fresh from paraformaldehyde, and permeabilized in PBS containing 10% horse serum and 0.3% Triton X-100. Cells were incubated in primary antisera overnight at 4°C with shaking in PBS containing 4% horse serum and 0.3% Triton X-100. The primary antibody was removed and the cells were washed four times in the same buffer and incubated with species-specific secondary antibody coupled to tetramethylrhodamine or fluorescence isothiocyanate (Kirkegaard and Perry, Gaithersburg, MD) for 3 h at room temperature. The secondary antibodies were removed and the cells were washed three times for 5 min in the same buffer and mounted in anti-fade medium (Vector Laboratories, Burlingame, CA). Cells were visualized on an Olympus AX-70 fluorescence microscope.
Antibodies
The antibodies, their sources, and the dilutions used in the reported studies are provided in Table 1 .
BrdU Labeling
On the day of labeling, cells were incubated in growth medium containing 50 M 2Ј-bromodeoxyuridine for 4 h. Following rinsing in Hanks' balanced salt solution, the cells were fixed in 4% formaldehyde prepared fresh from paraformaldehyde, for 1 h. Cells were permeabilized in PBS containing 0.3% Trition X-100 and treated with 2 N HCl for 30 min. Acid was neutralized by incubation in borate buffer, pH 8.4, for 30 min. Cells were incubated in anti-BrdU antibody (Developmental Studies Hybridoma Bank) using our standard conditions described above. To label cell nuclei, DAPI (4,6-diamidino-2-phenylindole) was added to the final wash for 10 min.
Catecholamine Histofluorescence
Cells synthesizing and storing catecholamines were detected by the method of Falck et al. (1962) (Howard and Bronner-Fraser, 1985; Howard and Gershon, 1993) . Catecholamines condense with formaldehyde in the absence of water at 80°C to form a specific fluorescent product with a characteristic excitation/emission of 420/480 nm, respectively. In these studies, the overall degree of catecholaminergic differentiation was remarkably striking in cells overexpressing transcripts encoding HAND genes compared to our standard growth condition in medium supplemented with 10 or 2% CEE. The degree of catecholaminergic development in the cultures constitutively expressing HAND gene products was substantially increased over the 10% control condition. A new rating scale for formaldehyde-induced catecholamine histofluorescence (FIF) was therefore created for these experiments. Table 2 shows the scheme used for scoring FIF.
The overall degree of differentiation was scored according to an arbitrary scale with 10 cells getting a rating of 1. Five to 10 random areas on each explant were counted and the average number of cells expressing catecholamine histofluorescence was determined; then the score for FIF was assigned according to the scheme outlined in Table 2 . In each experiment, three to four neural tube explants are plated per dish and each is scored according to the scheme outlined in Table 2 . For each experimental group, a minimum of three separate platings were analyzed. The mean score for each experimental group was then determined. Data are either presented as the mean score for FIF or as a percentage of the control mean score for FIF which would be set to 100%. In each case, the error bars represent standard error of the mean unless otherwise stated.
Construction of Retroviral Vectors
The entire sequence coding dHAND or eHAND was cloned into a Cla 12 NCO shuttle vector (Hughes et al., 1987) and then excised as a ClaI fragment. The ClaI fragment was cloned in the replication-competent retroviral expression vector RCAS(A) according to established procedures (Hughes et al., 1987; Morgan and Fekete, 1996) . The ClaI fragments were also cloned into a second replication-competent vector, RCAN (Hughes et al., 1987) lacking a promoter required for expression of the cloned sequence, as a control for virus expression. A line of chick embryo fibroblasts (CEF), DF-1, was transfected using calcium phosphate according to standard methods (Cepko, 1992) . The DF-1 cells are a continuous line of fibroblasts that were derived from East Lansing Line O chicken embryos that lack endogenous ASLV-like sequences. The DF-1 line developed spontaneously from a high seeding of 10-dayold embryonic fibroblasts (manuscript in preparation). Supernatants from the transfected cultures, containing infective virus, were collected and frozen until use. The viral titer was established on unconcentrated stocks. Viral titer was assessed every month by infecting CEF cells with serial dilutions of virus and counting the number of infected cells at 48 h of growth following immunocytochemical localization of the viral protein p19 using a specific antibody, 3C2, obtained from the Developmental Studies Hybridoma Bank.
Antisense Oligonucleotides
The antisense oligonucleotides (Srivastava et al., 1995) used in this study were dHAND, ACTCGGGGCTGTAGGAC, and eHAND, TCCTCCCGAACCGAACTC.
RESULTS
Neural crest-derived cells begin to condense to form primary sympathetic chain ganglia beginning around stage 16 (Hamburger and Hamilton, 1951) . We have used in situ hybridization (Barthe and Ivarie, 1994) to localize transcripts encoding dHAND and eHAND during early stages of avian embryogenesis (Fig. 1 ). Prior to Hamburger and Hamilton stage 17, the expression of transcripts encoding dHAND and eHAND is confined to the cardiac primordia in the cardiac crescent, sinus venosis, and looped heart tube and the extraembryonic mesoderm, as previously reported (Srivastava et al., 1995) (data not shown). Between Hamburger and Hamilton stages 17 and 19 (Hamburger and Hamilton, 1951) transcripts encoding dHAND and eHAND are expressed in sympathetic and enteric ganglia, distal pharyngeal pouches/branchial arches, and mandibular arch in regions associated with migrating neural crest cells and neural crest-derived structures (Figs. 1A and 1B). The expression of transcripts encoding dHAND in neural crestderived neural primordia is confined to sympathetic and enteric ganglia (Figs. 1A, 1C, and 1E), while transcripts encoding eHAND appear to be expressed in sympathetic ganglia exclusively (Fig. 1B) . These ganglia represent a sense-strand oligonucleotides, scrambled antisense dHANDϩeHAND oligonucleotides, and antisense dHANDϩeHAND oligonucleotides was assessed. Immunocytochemistry using antibodies that recognize neurofilament proteins and MAP2 was used to identify neurons. Under each condition, 50 M total oligonucleotide was added each day for the 7-day growth period. Neuronal development in the presence of oligonucleotides was compared to neuronal differentiation under control conditions after 7 days. Neuronal differentiation was not affected by sense or scrambled antisense oligonucleotides. Growth in the presence of antisense dHANDϩeHAND oligonucleotides significantly reduced neuronal development by 80 Ϯ 10% (P Ͻ 0.00001, ANOVA). Nine explants from three different platings were examined for sense and scrambled antisense conditions. The decrease in levels of transcript encoding eHAND was assessed at 7 days in culture using RT-PCR (Howard et al., 1995) . Total cellular RNA was prepared from 20 neural crest explants treated with 50 M total HAND antisense oligonucleotides or sense-strand control oligonucleotides. Two sets of primers were used, one specific for chick eHAND and the other specific for chick ␤-actin. PCR products were fractionated on a 1.5% agarose gel and quantified using NIH Image. The density of ethidium bromide-labeled products corresponding to eHAND or chick ␤-actin was determined and the ratio of eHAND to ␤-actin calculated (not shown). The percentage reduction of the normalized eHAND product from two determinations was 50.2%. This suggests that the effects we observe on the differentiation of neural crest-derived neurons are a result of modulating levels of transcripts encoding HAND genes (cf. Srivastava et al., 1995) .
subset of neural crest-derived peripheral ganglia. Transcripts encoding neither dHAND (Fig. 1C) nor eHAND have been detected in dorsal root ganglia. In the enteric nervous system, transcripts encoding dHAND are expressed in myenteric and submucosal ganglia (Fig. 1E) . Transcripts encoding eHAND are expressed by mesenchymal cells in the developing avian proximal gut (Fig. 1D ) but have not been detected in ganglia. Transcripts encoding dHAND and eHAND are expressed throughout the heart in the ventricles, atria, outflow tract, aortic arch, and pericardium (Srivastava et al., 1995) . We have not detected differential expression of transcripts encoding dHAND and eHAND in the developing avian heart. This overlapping pattern of expression of transcripts encoding dHAND and eHAND is different from that reported in rodent in which transcripts encoding dHAND are expressed in the right heart while transcripts encoding eHAND are expressed in the left heart (Srivastava et al., 1997; Riley et al., 1998; Firulli et al., 1998; Thomas et al., 1998) . Transcripts encoding dHAND and eHAND are expressed by cells in limb buds, as previously reported in rodents , and in the tail bud.
The restricted expression pattern of transcripts encoding dHAND and eHAND as well as their early time of appearance at the initial stages of gangliogenesis suggested an early role in phenotypic specification or expression of sympathetic neurons. To determine if HAND gene products function in early events of neurogenesis of sympathetic neural crest-derived peripheral ganglia we used antisense oligonucleotides to block expression of transcripts encoding dHAND and eHAND. In vitro application of antisense dHAND and eHAND oligonucleotides to neural crest cell explants results in a reduction of the number of neural crest-derived neurons differentiating in response to 10% CEE (Fig. 2) . Antisense oligonucleotides were added to neural tube plus neural crest explants for a period of 6 -7 days and neurons developing in the cultures were identified using antibodies directed against the neurofilament protein triplet and/or MAP2. Neural tube-derived cells were identified using an antibody directed against LIM1 and LIM2 (provided by Dr. Thomas Jessell, Columbia University); cells that had migrated away from neural tube explants never expressed the antigen recognized by this antibody. Antisense dHAND and eHAND oligonucleotide at 50 M, or both oligonucleotides at 25 M, was used to knockdown the expression of transcripts encoding dHAND and/or eHAND. The development of neural crest-derived neurons was assessed at 6 to 7 days by counting the number of cells expressing immunoreactivity for neurofilament proteins and/or MAP2. Four random fields were chosen in each explant and the number of immunoreactive cells counted. The mean number of cells expressing panneuronal markers counted under control conditions (10% CEE) was averaged for each of the experiments and set to 100%. The number of cells counted for each treatment condition (sense oligonucleotides, antisense oligonucleotides, scrambled antisense oligonucleotides) was averaged for that condition and expressed as a percentage of the control values for each experiment. In the presence of either antisense oligonucleotide alone little apparent difference in neuronal differentiation was observed compared to control cells grown in 10% CEE; growth in medium supplemented with 10% CEE is permissive for the differentiation of cholinergic and catecholaminergic neural crest-derived neurons (Howard and Bronner-Fraser, 1986) . Cells with a variety of morphological characteristics expressed neurofilaments and MAP2. Knockdown of transcripts encoding dHAND and eHAND resulted in a significant reduction (P Ͻ 0.0001) in the number of neural crest-derived cells expressing panneuronal characteristics; neuronal differentiation was reduced on average by 80 Ϯ 10% (mean Ϯ SD) (Fig. 2B) . A comparison of the representative fields indicated in Figs. 2A1 and 2A2 shows a 76.5% reduction in the number of neural crestderived cells expressing panneuronal markers; the kinds of cells counted are indicated by arrows. The neural tube is located at left of each image and is marked at the rightmost edge by a dashed white line. Treatment with 50 M either dHAND or eHAND antisense oligonucleotide individually had no apparent effect on the number of neural crestderived cells expressing panneuronal markers or the various morphological phenotypes that they express compared to control cells grown in 10% CEE. As a control for nonspecific influences of antisense oligonucleotides on differentiation of neural crest-derived neurons, sense-strand oligonucleotides and scrambled antisense oligonucleotides were tested for their ability to influence neuronal differentiation (Fig. 2B) . Neither sense nor scrambled antisense oligonucleotides had any detectable effect on the number of cells expressing the panneuronal markers neurofilament protein and MAP2.
Catecholaminergic neurons represent a subset of neural crest-derived neurons that differentiate in vitro in response to 10% CEE. As more than one neuronal phenotype is expressed in cultures of neural crest-derived cells, cells in sympathetic ganglia express transcripts encoding HAND gene products, and blockade of expression of transcripts encoding HAND gene products influences acquisition of panneuronal characteristics by neural crest-derived cells (Fig. 2) , we asked if catecholaminergic phenotypic expression was influenced specifically by reducing expression of transcripts encoding dHAND and eHAND (Fig. 3) . Neural crest-derived cells were grown in medium supplemented with 10% CEE in the presence and absence of 25 M each antisense dHAND and eHAND oligonucleotide. Antisense oligonucleotides were added for the 7-day culture period (0 -7), during the critical period for CEE-derived factors (culture days 0 -4), or after the critical period for CEEderived factors (culture days 4 -7). Catecholaminergic differentiation was assessed using FIF, as described under Materials and Methods. There was a significant reduction (P Ͻ 0.001) in catecholaminergic differentiation in response to antisense oligonucleotide-mediated knockdown of transcripts encoding dHAND and eHAND (Fig. 3) . Catecholaminergic differentiation was reduced 62% during the critical period for CEE-derived factors (days 0 -4) and 58% after the critical period (days 4 -7). This reduction in catecholaminergic development was not significantly different (P Ͼ 0.1) from the 52% reduction achieved with treatment during the entire 7-day culture period. The influence on generation of crest-derived neurons (Fig. 2) and the expression of catecholaminergic phenotypic characteristics (Fig. 3) suggest that both neurogenesis and subtype-specific gene expression are regulated by HAND proteins. Measurements based on cell counts of panneuronal markers examine the population of neurons in these cultures, which includes cells which differentiate as catecholaminergic neurons, cholinergic neurons, and serotonergic neurons. The measurement of FIF assesses only differentiation of the catecholaminergic subpopulation of cells such that the FIF cells represent an exclusive subgroup of the total.
In order to demonstrate that cells which did not differentiate into neurons in the presence of antisense oligonucleotide actually had taken up the oligonucleotide, we coupled our antisense oligonucleotides to fluorescein-labeled Penetratin (Oncor, Inc., Gaithersburg, MD). This small peptide is a 16-amino-acid fragment of the Drosophila antennapedia homeodomain which acts as a transmembrane carrier (Joliot et al., 1991) . The fluorescent label makes it possible to identify cells which have taken up the oligonucleotide. The concentration of Penetratin-coupled antisense oligonucleotides needed to achieve equivalent reduction in neuronal development to our uncoupled oligonucleotides is 1-10 M. Cells were classified as neurons if they expressed neurofilament proteins and/or MAP2, which were used as panneuronal markers. Neurons were identified immunocytochemically and visualized with tetramethylrhodaminecoupled species-specific secondary antibodies. Neural crest plus neural tube explants were grown in the presence of 10% CEE and 1 M Penetratin-coupled dHAND and eHAND antisense oligonucleotides for 7 days. Treatment of neural crest-derived cells with 1 M fluorescent antisense oligonucleotides results in a marked decrease of neurogenesis of neural crest-derived neurons (Fig. 4A ) without affecting differentiation of neural tube-derived neurons (Fig. 4B) ; neural tube-derived cells do not express transcripts encoding HAND genes and their neuronal differentiation should therefore be unaffected by knockdown of transcripts encoding them. There is a small subset of neural crest cells that differentiate into neurons even in the presence of antisense oligonucleotides (Fig. 4D ) although the majority of cells taking up the oligonucleotides do not express neuronal markers (Figs. 4A and 4C ). In the presence of antisense oligonucleotides approximately 20 -30% of the normal rate of neurogenesis occurs. The data suggest that HAND gene products function early in neurogenesis of neural crestderived neurons as well as in the phenotypic expression of catecholaminergic characteristics.
To determine if the expression of dHAND and/or eHAND is sufficient to induce/support the differentiation of catecholaminergic neurons in vitro, we used retrovirusmediated gene transfer to transduce dHAND and eHAND into neural crest-derived cells. Neural crest explants were plated in medium containing 2.5 ϫ 10 6 PFU virus collected from CEF cells transfected with RCASd, RCASe, RCASdϩRCASe (Fig. 5) , or RCAN constructs (not shown). The neural crest cells were maintained for 7 days in medium supplemented with 2% CEE (Fig. 5A) , which does not support catecholaminergic differentiation of neural crest-derived cells, or 10% CEE (Fig. 5B) , which does support catecholaminergic differentiation (Fauquet et al., 1981; Bronner-Fraser, 1985, 1986; Dupin and Le Douarin, 1995; Howard and Gershon, 1993) . The differentiation of catecholaminergic neurons was assessed following immunohistochemistry for formaldehyde-induced catecholamine fluorescence (Falk et al., 1962; Dupin and LeDouarin, 1995; Maxwell and Forbes, 1987; Bronner-Fraser, 1985, 1986; Howard and Gershon, 1993) . When dHAND and eHAND are introduced into neural crest cells grown under restrictive conditions for catecholaminergic differentiation in medium supplemented with 2% CEE (Fig. 5) , significant numbers (analysis of variance and
FIG. 3.
Catecholaminergic differentiation is reduced by antisense oligonucleotide blockade of transcripts encoding dHAND and eHAND. Neural crest-derived cells were grown in medium supplemented with 10% CEE and 25 M each antisense dHAND and eHAND oligonucleotide. Antisense oligonucleotides were added for the 7-day culture period (0 -7), during the critical period for CEE-derived factors (0 -4), or after the critical period for CEEderived factors (4 -7). Catecholaminergic differentiation, assessed by FIF, of cells treated with antisense oligonucleotides was compared to control cells. The level of catecholaminergic differentiation was scored as described under Materials and Methods. There was a significant reduction in the degree of catecholaminergic differentiation in response to blocking expression of transcripts encoding dHAND and eHAND. The reduction in catecholaminergic development was not significantly different when treatment during or after the critical period for embryo-derived growth factors is compared to treatment for the 7-day culture period. This experiment was repeated four times. In each experiment, three or four explants were counted per condition. The data are presented as means Ϯ SEM; statistical significance was determined by ANOVA.
Duncan's multiple range post hoc test) of neural crestderived cells differentiate into catecholaminergic neurons based on the expression of catecholamine neurotransmitter (Fig. 5A) . Under this condition, constitutive expression of dHAND, eHAND, and dHAND plus eHAND resulted in catecholaminergic differentiation of neural crest-derived cells. All treatments resulted in significant differentiation of catecholaminergic neurons (P Ͻ 0.00001) compared to cells grown in medium supplemented with 2% CEE alone. When neural crest cells express HAND gene products under a restrictive growth condition for catecholaminergic differentiation, the level of catecholaminergic phenotypic expression obtained is equivalent to that observed in growth medium supplemented with 10% CEE and significantly greater compared to cells grown in medium supplemented with 10% CEE but not overexpressing HAND gene products (P Ͻ 0.001).
Cells grown in 10% CEE and infected with RCASd or RCASdϩRCASe showed an increase in the degree of differentiation into catecholaminergic cells compared to neural crest-derived cells grown in 10% CEE alone (Figs. 5B and 5C). Two-way analysis of variance showed a significant effect of both growth medium supplements (10% CEE versus 2% CEE) as well as expression of HAND gene   FIG. 4 . Effects of treatment with antisense dHAND and eHAND oligonucleotides are specific. Neural crest plus neural tube explants were grown in the presence of 10% CEE and 1 M Penetratin-coupled dHAND and eHAND antisense oligonucleotides for 7 days; these oligonucleotides were tagged with fluorescein as an internal marker. Neurons were visualized with antibodies directed against neurofilament proteins and MAP2 using rhodamine-coupled species-specific secondary antibodies. 
FIG. 5.
Constitutive expression of transcripts encoding dHAND and eHAND is sufficient for catecholaminergic differentiation of neural crest-derived cells. Neural crest cells were plated in medium supplemented with 2% (A) or 10% CEE (B) in the presence or absence of 2.6 ϫ 10 6 PFU virus obtained from CEF cells transfected with RCASd and/or RCASe constructs. FIF was assessed at 7 days in vitro. (A) Expression of dHAND, eHAND, and dHANDϩeHAND was sufficient to support catecholaminergic differentiation under restrictive (2% CEE) growth conditions under which the differentiation of catecholaminergic cells is not supported Bronner-Fraser, 1985, 1986 ). The expression of HAND genes not only significantly increased (P Ͻ 0.0001) catecholaminergic differentiation of neural crest-derived cells but appeared to be sufficient to induce expression of catecholaminergic phenotypic characteristics. (B) Overexpression of dHAND and dHANDϩeHAND under permissive conditions resulted in a significant increase (P Ͻ 0.0001) over control of the number of cells differentiating as catecholaminergic neurons. Overexpression of eHAND in a growth factor background that supports catecholaminergic differentiation did not significantly increase the expression of this phenotype. (C) Neural crest explants were plated in medium supplemented with 10% CEE in the absence (1) or presence of RCASd (2), RCASe (3), or RCASdϩRCASe (4) for 7 days and the differentiation of catecholaminergic neurons was assessed based on the expression of tyrosine hydroxylase (TH). TH was detected immunocytochemically and visualized following incubation in tetramethylrhodamine species-specific secondary antibody. The relative density of cells expressing TH in response to induced expression of dHAND and/or eHAND is similar to that shown in B for neurotransmitter expression. The enhancement in the number of catecholaminergic cells developing in response to RCASd or RCASdϩRCASe compared to control or RCASe is apparent. Explants from three to eight platings were examined for each condition. Catecholaminergic differentiation of cells infected with control RCAN constructs did not vary from cells grown in medium supplemented with 10% CEE. Under each condition, the differentiation of untreated control cells was compared to the differentiation of cells infected with RCANd/RCANe. Infection of neural crest cells with RCANd or RCANe had no effect on their differentiation compared to untreated controls. products (P Ͻ 0.0001). Detailed post hoc analysis using Duncan's multiple range test showed a significant increase in catecholaminergic differentiation when neural crestderived cells expressed dHAND (P Ͻ 0.001) but not eHAND (P Ͻ 0.02). The expression of eHAND did not support catecholaminergic differentiation above the level normally observed in growth medium supplemented with 10% CEE alone. The expression of dHAND and eHAND together resulted in enhanced catecholaminergic differentiation compared to cells constitutively expressing dHAND or eHAND individually or to cells grown in medium supplemented with 10% CEE and not constitutively expressing HAND gene products (P Ͻ 0.00005). The viral titer of 2 ϫ 10 6 PFU RCASd or RCASe was maximal for the differentiation of catecholaminergic cells when either dHAND or eHAND was expressed in cells individually and is not significantly different from values reported for infection of neural crest-derived cells with RCAS constructs inducing the constitutive expression of type I BMP receptor (Varley et al., 1998) , which results in an increase in the number of cells expressing tyrosine hydroxylase (TH).
To delineate the role that HAND gene products might play in specification or phenotypic expression of neural crest-derived cells, the cell division index was determined on culture day 4 by counting the number of cells incorporating BrdU in 30 randomly selected microscope fields and dividing that number by the total number of cells in the field stained with DAPI (Fig. 6) . Cell counts were determined on culture day 4 for cells grown in medium supplemented with 10% CEE in the presence or absence of 2 ϫ 10 5 PFU RCASd, RCASe, or RCASdϩRCASe. The number of cells incorporating BrdU and stained with DAPI was determined in three experiments (Fig. 6 ) and the mean cell division index was compared using analysis of variance and the Bonferroni post hoc test. The 4-day time point was chosen because at this time cells remain responsive to growth factor manipulation of neuronal phenotypic expression (Howard and Gershon, 1993) and it gives cells infected with RCAS time to generate and respond to HAND protein products (Lo et al., 1998; Varley et al., 1998; Martinsen and Bronner-Fraser, 1998) . The induced expression of dHAND and/or eHAND resulted in a significant decrease (P Ͻ 0.001) in the number of dividing cells compared to control. No significant difference was found between the effectiveness of dHAND or eHAND to reduce the number of dividing cells. The expression of both dHAND and eHAND significantly increased the number of cells withdrawing from the cell cycle compared to eHAND (P Ͻ 0.05) but not dHAND (P Ͼ 0.05). The data demonstrate that expression of dHAND and/or eHAND causes neural crest-derived cells to exit the cell cycle although eHAND is modestly less effective than dHAND and eHAND together. The data suggest that expression of these gene products supports differentiation into neurons as neural crest-derived cells withdraw from the cell cycle. An effect on differential survival of a subset of neural crest-derived cells was ruled out by demonstrating a lack of apoptotic cells, based on TUNEL assay, on culture day 4. We do not routinely observe cell death in neural crest cultures.
To further assess the influence of constitutive expression of HAND gene products on neural crest-derived cells, the number of cells expressing the panneuronal markers neurofilament and microtubule-associated (MAP2) proteins and the viral gag-encoded matrix protein (p19) was determined. For cells infected with RCASd, 92% of cells expressing neurofilaments and MAP2 also expressed p19. In neural crest-derived cells infected with RCASe, 85% of cells expressing neurofilaments and MAP2 also expressed p19. To determine if HAND gene products function cell autonomously, the number of cells expressing TH was examined in neural crest-derived cells grown in the presence of RCASd, RCASe, or RCASdϩRCASe for 7 days in medium supplemented with 2% CEE (Fig. 7) . For neural crestderived cells grown in the presence of RCASdϩRCASe for 7 days, 95% of cells expressing TH also expressed p19. For cells grown in the presence of either RCASd or RCASe, 85 and 88%, respectively, of cells that expressed TH also expressed viral matrix protein. Not all cells expressing p19 differentiated as neurons over the time course of these experiments; in most fields there were some cells expressing viral matrix protein but not TH, indicating that all cells expressing virus did not differentiate as catecholaminergic neurons.
FIG. 6.
Expression of HAND gene products induces neural crestderived cells to exit from the cell cycle. Neural crest cells were grown in medium supplemented with 10% CEE for 4 days in the absence and presence of 2 ϫ 10 6 PFU RCASd, RCASe, or RCASdϩRCASe. On day 4, cells were incubated in BrdU as described under Materials and Methods and labeled with DAPI. Expression of HAND gene products results in a significant decrease in the cell division index in the cultures, suggesting that the observed increase in neuronal differentiation is the result of cells leaving the cell cycle and differentiating as catecholaminergic neurons. Data are presented as the means ϩ SEM for three experiments for counts of a total of 30 random fields per condition. Data analysis is based on analysis of variance and the Bonferroni post hoc test.
DISCUSSION
We have presented evidence that the HAND genes have a pivotal role in the development of neural crest-derived catecholaminergic neurons. The early time of expression as well as the confined localization of cells expressing transcripts encoding dHAND and eHAND suggests that products of these genes have an early role in phenotype specification and/or phenotypic expression of neural crest-derived cells of the catecholaminergic lineage.
The expression of transcripts encoding dHAND and eHAND in sympathetic ganglia at the time that the ganglia are forming suggests a possible role in lineage segregation or specification by neural crest-derived cells. Transcripts encoding HAND gene products do not appear to be expressed by migrating neural crest cells, obviating a potential role in localization of neural crest-derived neuron precursors. The temporal expression pattern of transcripts encoding dHAND and eHAND is similar to that of CASH, the avian homologue of MASH1 , which has been shown to be important for the expression of both panneuronal and sympathetic neuron-specific characteristics Hirsch et al., 1998; Lo et al., 1998) . The spatial and temporal overlap in the expression of transcripts encoding dHAND and eHAND in sympathetic ganglia suggests that the products of these two genes may function in concert. The differential patterns of expression of transcripts encoding dHAND and eHAND in the enteric nervous system suggest that dHAND and eHAND can serve different functions developmentally and that their functions are not redundant as might be inferred from their expression pattern in the developing avian heart (Srivastava et al., 1995) .
To begin to determine the role of HAND gene products in catecholaminergic differentiation of neural crest-derived cells, we asked if blocking expression of transcripts encoding dHAND and eHAND, by the addition in vitro of dHAND and eHAND antisense oligonucleotides, results in a reduction of the number of neural crest-derived cells expressing panneuronal characteristics in response to 10% CEE. The number of cells expressing the panneuronal markers neurofilament proteins and MAP2 was significantly reduced as a result of antisense oligonucleotide knockdown of transcripts encoding dHAND and eHAND. We identified cells having taken up the oligonucleotides by coupling them to a fluorescinated carrier protein. Both neural crest-derived cells and neural tube-derived cells took up the antisense oligonucleotides but the expression of panneuronal characteristics was affected only in neural crest-derived cells; this suggests that effects of reducing transcript levels are specific as the differentiation of neural tube-derived neurons, which do not express transcripts encoding dHAND or eHAND, was unaffected. Not all cells that took up antisense oligonucleotides were inhibited from expressing panneuronal markers. This is not unexpected because more than one neuronal phenotype differentiates in response to 10% CEE in vitro (Howard and Bronner-Fraser, 1986) ; both catecholaminergic and cholinergic neurons differentiate from neural crest-derived cells exposed to 10% CEE in vitro. Some cells may have taken up the oligonucleotides following neuronal differentiation. The observed reduction in neurogenesis suggests that the majority of neural crest-derived cells which take up antisense dHAND and eHAND oligonucleotides do not differentiate into neurons and that the effects are neural crest specific.
We examined the effect on phenotypic expression of antisense blockade of transcripts encoding dHAND and eHAND by assessing the influence on catecholaminergic differentiation of neural crest-derived cells. The number of neural crest-derived cells differentiating into catecholaminergic neurons was significantly reduced in response to antisense oligonucleotide blockade of transcripts encoding dHAND and eHAND. Blockade of expression of transcripts encoding dHAND and eHAND influences several aspects of neurogenesis of neural crest-derived cells and this influence can be realized both at early and at later stages of neuronal differentiation. The data suggest that the HAND genes may have a dual role in neuronal specification and catecholaminergic phenotypic expression. There is a critical period, 3 days following migration of neural crest cells from the neural tube, during which neural crest-derived cells must receive signals from growth factors required for catecholaminergic differentiation (Howard and Gershon, 1993; Maxwell and Forbes, 1990; Ziller et al., 1987; Varley et al., 1995) . The finding that the application of antisense oligonucleotides during or after the critical period for CEEderived factors does not influence the magnitude of the reduction in catecholaminergic differentiation supports the contention that HAND genes function at more than one stage of neuronal specification/differentiation of neural crest-derived cells. If HAND gene products function exclusively in specification or other early stage of lineage segregation, treatment with antisense oligonucleotides after the critical period for CEE-derived factors should not have affected catecholaminergic differentiation unless precursor cells remain undifferentiated but responsive. If the role of the HAND genes is primarily in differentiation, the reduction in catecholaminergic development should have been greater during the critical period than after. The fact that blockade of transcript expression during and after the critical period for CEE-derived factors results in an equivalent reduction in the percentage of cells expressing catecholaminergic characteristics suggests either that HAND gene products serve more than one function or that the critical period for growth factor effects is not related to the functional role of HAND gene products in neurogenesis. The reduction in the percentage of neural crest-derived cells expressing panneuronal characteristics as well as a reduction in the number of cells differentiating as catecholaminergic neurons in these studies suggests that the expression of dHAND and/or eHAND may be necessary for a subset of neural crest-derived cells to differentiate into catecholaminergic neurons by acting in concert to support aspects of early events in neurogenesis in addition to being required for the expression of catecholaminergic phenotypic characteristics.
Since the expression by neural crest-derived cells of panneuronal markers as well as the differentiation into catecholaminergic neurons is influenced by the expression of transcripts encoding dHAND and eHAND, we wanted to determine if the expression of HAND gene products is sufficient for catecholaminergic differentiation of neural crest-derived cells. Retrovirus-mediated gene transfer is a useful method of overexpressing genes in defined sets of cells. We have used retrovirus-mediated gene transfer to induce the expression of dHAND and eHAND in neural crest-derived cells in culture. Neural crest-derived cells differentiate into catecholaminergic neurons in response to growth factors present in 10% CEE BronnerFraser, 1985, 1986) . Constitutive expression of dHAND in neural crest-derived cells grown in a permissive growth factor environment in the presence of 10% CEE results in a significant increase in the number of cells differentiating as catecholaminergic neurons. This result suggests that growth factors required for catecholaminergic differentiation might induce the expression of dHAND. That expression of dHAND may be sufficient for neural crest-derived cells to express a catecholaminergic phenotype is supported by the finding that catecholaminergic neurons differentiate in cultures in which the growth conditions (2% CEE) independent of HAND gene expression do not support catecholaminergic differentiation.
It is quite interesting that the expression of eHAND does not increase the catecholaminergic differentiation of crestderived cells in response to 10% CEE. This suggests that the endogenous growth factors most likely support expression of eHAND and that under permissive conditions the effects of overexpression are not synergistic. However, eHAND gene products can independently support catecholaminergic differentiation of neural crest-derived cells in the absence of growth factor support. dHAND and eHAND appear to function in concert to support catecholaminergic differentiation since under both permissive and restrictive growth factor conditions, the induced expression of these genes results in significant increases in the number of cells expressing catecholaminergic characteristics. Unlike the expression of MASH1, which does not appear to be sufficient for the expression of catecholaminergic characteristics (Johnson et al., 1992) , the expression of both dHAND and eHAND appears to be sufficient for the expression of catecholaminergic neurons in vitro. There is an interaction between the effects of dHAND and eHAND as there is a marked enhancement of catecholaminergic differentiation in neural crest-derived cells expressing both dHAND and eHAND. The synergistic effect of expressing dHAND and eHAND together could be the result of direct interaction of these bHLH proteins in the same cells or an interaction of cells expressing either dHAND or eHAND. It is not possible to distinguish these alternative mechanisms currently. That constitutive expression of eHAND independent of dHAND does not cause an increase in catecholaminergic differentiation under permissive growth conditions, which raises the possibility that growth/differentiation factors present in CEE support the expression of eHAND and that its effects are maximal under that growth condition.
Bone morphogenetic protein (BMP) supports the differentiation of catecholaminergic cells (Reissman et al., 1996; Varley et al., 1995; Varley and Maxwell, 1996) as well as inducing the expression of MASH1 (Shah et al., 1996; Lo et al., 1997) and transcripts encoding HAND proteins (M. Howard, unpublished results) . Constitutive expression of MASH1, using retroviral-mediated gene transfer, induces an increased and sustained responsiveness to bone morphogenetic protein and competence to differentiate into neurons (Lo et al., 1997) . Bone morphogenetic protein 4 will support catecholaminergic differentiation of neural crest-derived cells in medium supplemented with 2% CEE to the same degree as that observed in cells expressing both dHAND and eHAND (M. Howard, unpublished observation). Expression of a constitutively active form of the BMP-1A receptor in neural crest cells in vitro promotes the differentiation of catecholaminergic neurons (Varley et al., 1998) , suggesting a link between the role of BMP and the products of the HAND genes. It is possible that the cellular function of dHAND occurs upstream of MASH1 being required for neuronal specification, while MASH1 is required for the differentiation of committed neuronal precursor cells (Sommer et al., 1995) . Alternatively, the proximate time of expression of transcripts encoding dHAND and CASH indicates that these two transcriptional regulators may function in concert to regulate aspects of sympathetic neuroblast differentiation. The expression of dHAND and/or eHAND might alter the fate of cells and/or function as a differentiation factor for precursors that are competent to follow the catecholaminergic lineage. Precursor cells in all three autonomic lineages express transcripts encoding MASH1. It is tempting to speculate that one role of the HAND genes, which have a restricted pattern of expression, is to demarcate neural crest-derived cells that will differentiate as sympathetic neurons (cf. Groves and Anderson, 1996) .
As might be expected for bHLH transcription factors, dHAND and eHAND appear to function in concert. The reduction in transcripts encoding either transcription factor independently did not have an appreciable effect on the differentiation of neurons from neural crest-derived precursors. Antisense blockade in vivo of transcripts encoding dHAND and eHAND has been shown to arrest development at the looped heat stage in avian embryos (Srivastava et al., 1995) . In this study, there was no effect of either antisense oligonucleotide when used individually, suggesting that dHAND and eHAND function in concert. In avians, the pattern of expression of transcripts encoding dHAND and eHAND, based on in situ hybridization, shows an overlapping distribution (Srivastasa, 1995) both spatially and temporally. The finding that expression of dHAND and eHAND must be blocked simultaneously in order to observe an influence on cardiac morphogenesis has been interpreted to mean that in avians these two transcription factors are redundant (Srivastava et al., 1995) . An examination of the nucleotide sequences encoding the DNA binding domains of dHAND and eHAND reveals that they are quite divergent, suggesting that these factors bind to different DNA motifs. That the function of dHAND and eHAND might not be redundant in avians is also suggested by our finding that dHAND but not eHAND, when overexpressed under permissive conditions for catecholaminergic differentiation, supports an increased degree of catecholaminergic development. The expression of eHAND alone, while supporting catecholaminergic development, was not able to increase it over that seen with 10% CEE, suggesting that eHAND and dHAND might dimerize with different partners and bind to independent regions of DNA. It is tempting to speculate that eHAND might act cell autonomously, both influencing cell-type specification and inducing the expression of signaling molecules required by sympathetic neuroblasts. If HAND gene products function exclusively in lineage specification there should be a one-to-one correspondence between cells expressing HAND genes and those differentiating as catecholaminergic neurons. The finding that between 83 and 88% of cells expressing TH also expressed either dHAND or eHAND suggests that both cell-autonomous influences and extrinsic signaling may be mediated by HAND gene products. In experiments in which retrovirus-mediated gene transfer was used to overexpress HAND genes, although a majority of neurons expressed viral protein there were many cells expressing p19 that did not express TH. It seems likely that more than one cell type might express HAND gene products and that their functions may change as development proceeds. The expression of dHAND or eHAND by neural crest cells causes their exit from the cell cycle and differentiation as catecholaminergic neurons as evidenced by a reduction in the cell division index. This result suggests that rather than supporting a survival function or proliferation of neuroblasts, HAND gene products support the lineage choice and phenotypic expression of sympathetic neuron-specific traits. There is no apparent difference in the overall growth of neural crest-derived cells in an explant in response to overexpression of dHAND or eHAND. In order to determine if selective cell survival was influenced by the expression of HAND gene products, a TUNEL assay was used to examine apoptosis under our growth conditions. Few apoptotic cells were detected in our cultures on day 4, suggesting that other mechanisms of action might account for the increased expression of catecholaminergic neurons that we find in response to overexpression of HAND genes. Although difficult to assess directly, there is no apparent influence on melanogenesis in vitro in response to expression of dHAND or eHAND. Melanocytes differentiate in vitro in a pattern similar to that seen in control cells not overexpressing HAND genes. The development of nonneuronal phenotypes, exclusive of melanocytes, as well as determination of the total cell number, is difficult to assess because of the mass culture conditions as well as a lack of markers for other potential derivatives developing in the cultures.
The HAND gene products appear to function at several points along the pathway of development for a subset of neural crest-derived cells destined to become catecholaminergic neurons. We predict that dHAND functions early and has a role in the commitment of these cells to the autonomic lineage. Together, the HAND genes appear to function at a later stage of phenotypic expression. We hypothesize that once cells become committed to a neuronal lineage, MASH1 and HAND genes may function in concert to support the differentiation of neural crest-derived cells into catecholaminergic neurons. It is interesting that in embryos carrying a null mutation in the MASH1 gene, the expression of transcripts encoding eHAND appears to be abolished, suggesting that eHAND functions downstream of MASH1 (Ma et al., 1997) . It is possible that one role of MASH1 is the transcriptional regulation of eHAND and that these two transcription factors function in concert to influence expression of sympathetic neuron-specific phenotypic characteristics. The hierarchical nature of bHLH function, the demonstrated effects of MASH1 and the HAND genes in differentiation of a subset of autonomic neurons, and the fact that the expression patterns of transcripts encoding dHAND and eHAND overlap with a subset of neural crest-derived ganglia expressing MASH1 (Anderson, 1993; Blaugrund et al., 1996; Srivastasa et al., 1995; Cserjesi et al., 1995) suggest that the HAND genes have a significant role in sympathetic neuronal development.
